Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pneumococcal Vaccine is the most effective means to prevent pneumonia, bacteremia and meningitis caused by pneumococcal bacteria.
The global Pneumococcal Vaccine market value is expected to grow at a CAGR of 2% during the forecast period 2019-2026. According to the report, the market will be worth about $6.7 billion in 2019 and could grow to $7.9 billion by 2026.
The increasing government efforts to make vaccinations available globally to raise awareness of vaccination programme and the increase in cases of pneumococcal disease caused by pathogens are expected to boost the market. The introduction of a pneumococcal vaccine with a broader serotype coverage, and the increasing support of governments and non-profit organizations for the supply, supply and distribution of pneumococcal vaccines in developing regions, are also expected to boost market growth.
The report details the trend, potential and market size of Pneumococcal Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pneumococcal Vaccinemarket, defines the market attractiveness level of Pneumococcal Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pneumococcal Vaccine industry, describes the types of Pneumococcal Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pneumococcal Vaccine market and the development prospects and opportunities of Pneumococcal Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pneumococcal Vaccine market in Chapter 13.
By Player:
Pfizer
CDIBP
MSD
GSK
Sanofipasteur
By Type:
Pneumococcal Polysaccharide Vaccines
Pneumococcal Conjugate Vaccines
By End-User:
Child
Adult
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pneumococcal Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pneumococcal Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pneumococcal Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pneumococcal Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pneumococcal Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Pneumococcal Vaccine Consumption (2017-2022)
-
7.2 United States Pneumococcal Vaccine Consumption (2017-2022)
-
7.3 Europe Pneumococcal Vaccine Consumption (2017-2022)
-
7.4 China Pneumococcal Vaccine Consumption (2017-2022)
-
7.5 Japan Pneumococcal Vaccine Consumption (2017-2022)
-
7.6 India Pneumococcal Vaccine Consumption (2017-2022)
-
7.7 South Korea Pneumococcal Vaccine Consumption (2017-2022)
8 Region and Country-wise Pneumococcal Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.4 China Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.6 India Pneumococcal Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Pneumococcal Vaccine Consumption Forecast (2022-2028)
9 Global Pneumococcal Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Pneumococcal Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Pneumococcal Polysaccharide Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pneumococcal Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Pneumococcal Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Child Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adult Consumption and Growth Rate (2017-2022)
10 Global Pneumococcal Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Pneumococcal Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Pneumococcal Polysaccharide Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pneumococcal Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pneumococcal Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Child Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)
11 Global Pneumococcal Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pneumococcal Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pneumococcal Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pneumococcal Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pneumococcal Vaccine Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Pneumococcal Vaccine Product and Service
-
14.2 CDIBP
-
14.2.1 CDIBP Company Details
-
14.2.2 CDIBP Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CDIBP Pneumococcal Vaccine Product and Service
-
14.3 MSD
-
14.3.1 MSD Company Details
-
14.3.2 MSD Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 MSD Pneumococcal Vaccine Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Pneumococcal Vaccine Product and Service
-
14.5 Sanofipasteur
-
14.5.1 Sanofipasteur Company Details
-
14.5.2 Sanofipasteur Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofipasteur Pneumococcal Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pneumococcal Vaccine
-
Figure Pneumococcal Vaccine Picture
-
Table Global Pneumococcal Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumococcal Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumococcal Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pneumococcal Vaccine Consumption by Country (2017-2022)
-
Figure United States Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumococcal Polysaccharide Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Child Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Polysaccharide Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumococcal Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Child Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pneumococcal Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pneumococcal Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pneumococcal Vaccine Product and Service
-
Table CDIBP (Foundation Year, Company Profile and etc.)
-
Table CDIBP Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table CDIBP Pneumococcal Vaccine Product and Service
-
Table MSD (Foundation Year, Company Profile and etc.)
-
Table MSD Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table MSD Pneumococcal Vaccine Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Pneumococcal Vaccine Product and Service
-
Table Sanofipasteur (Foundation Year, Company Profile and etc.)
-
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofipasteur Pneumococcal Vaccine Product and Service
-
